119 related articles for article (PubMed ID: 9427790)
1. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer.
Uegaki K; Nio Y; Inoue Y; Minari Y; Sato Y; Song MM; Dong M; Tamura K
Anticancer Res; 1997; 17(5B):3841-7. PubMed ID: 9427790
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor and its receptor as prognostic indicators in Chinese patients with pancreatic cancer.
Dong M; Nio Y; Guo KJ; Tamura K; Tian YL; Dong YT
Anticancer Res; 1998; 18(6B):4613-9. PubMed ID: 9891528
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness.
Yamanaka Y; Friess H; Kobrin MS; Buchler M; Beger HG; Korc M
Anticancer Res; 1993; 13(3):565-9. PubMed ID: 8317885
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and transforming growth factor alpha expression in papillary and nonpapillary renal cell carcinoma: correlation with metastatic behavior and prognosis.
Uhlman DL; Nguyen P; Manivel JC; Zhang G; Hagen K; Fraley E; Aeppli D; Niehans GA
Clin Cancer Res; 1995 Aug; 1(8):913-20. PubMed ID: 9816062
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival after radical resection for pancreatic head and ampullary cancer: a potential role for the EGF-R.
Smeenk HG; Erdmann J; van Dekken H; van Marion R; Hop WC; Jeekel J; van Eijck CH
Dig Surg; 2007; 24(1):38-45. PubMed ID: 17369680
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.
Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Branković-Magić M; Kanjer K; Gavrilović D; Mitrović L; Borojević N; Vukotić D; Spuzić I
J Exp Clin Cancer Res; 1999 Sep; 18(3):347-55. PubMed ID: 10606181
[TBL] [Abstract][Full Text] [Related]
7. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
Piyathilake CJ; Frost AR; Manne U; Weiss H; Bell WC; Heimburger DC; Grizzle WE
Clin Cancer Res; 2002 Mar; 8(3):734-44. PubMed ID: 11895903
[TBL] [Abstract][Full Text] [Related]
9. Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma.
Yeh TS; Tseng JH; Liu NJ; Chen TC; Jan YY; Chen MF
Arch Surg; 2005 Dec; 140(12):1184-90. PubMed ID: 16365240
[TBL] [Abstract][Full Text] [Related]
10. Correlation of postoperative survival and angiogenic growth factors in pancreatic carcinoma.
Knoll MR; Rudnitzki D; Sturm J; Manegold BC; Post S; Jaeger TM
Hepatogastroenterology; 2001; 48(40):1162-5. PubMed ID: 11490824
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-receptor expression correlates with tumor cell proliferation and prognosis in gastric cancer.
Jonjić N; Kovac K; Krasević M; Valković T; Ernjak N; Sasso F; Melato M
Anticancer Res; 1997; 17(5B):3883-8. PubMed ID: 9427797
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
[TBL] [Abstract][Full Text] [Related]
13. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival.
Casneuf VF; Fonteyne P; Van Damme N; Demetter P; Pauwels P; de Hemptinne B; De Vos M; Van de Wiele C; Peeters M
Cancer Invest; 2008 Oct; 26(8):852-9. PubMed ID: 18853313
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.
Juuti A; Louhimo J; Nordling S; Ristimäki A; Haglund C
J Clin Pathol; 2006 Apr; 59(4):382-6. PubMed ID: 16467169
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor-immunohistochemical detection and clinical significance for treatment of primary breast cancer.
Schroeder W; Biesterfeld S; Zillessen S; Rath W
Anticancer Res; 1997; 17(4A):2799-802. PubMed ID: 9252718
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor expression in human pancreatic cancer: Significance for liver metastasis.
Tobita K; Kijima H; Dowaki S; Kashiwagi H; Ohtani Y; Oida Y; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2003 Mar; 11(3):305-9. PubMed ID: 12579331
[TBL] [Abstract][Full Text] [Related]
18. Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.
Juuti A; Nordling S; Louhimo J; Lundin J; Haglund C
J Clin Pathol; 2004 Nov; 57(11):1151-5. PubMed ID: 15509674
[TBL] [Abstract][Full Text] [Related]
19. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
20. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
